Skip to main content English

Detail

Priv.-Doz. Dr. Azadeh Hojreh

Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of General and Paediatric Radiology)
Position: Chief physician

ORCID: 0000-0002-4556-1931
T +43 1 40400 39395
azadeh.hojreh@meduniwien.ac.at

Further Information

Keywords

Biliary Atresia; Child Abuse; Cholangiopancreatography, Magnetic Resonance; Congenital Abnormalities; Contrast Media; Cystic Fibrosis; Kidney Diseases; Liver; Lung Diseases, Interstitial; Pediatrics; Radiation Protection

Research group(s)

  • Pediatric Allergology and Pulmonology
    Research Area: Pediatric Allergology: Primary food allergies (IgE- and non-IgE-mediated),new markers of diagnosis (BAT), food challenges; allergen-specific preventive immuntherapy trial in 4 year old children Pediatric Pulmonology: cystic fibrosis treatment trials
    Members:
  • Peadiatric thoracic and abdominal imaging research group
    Head: Azadeh Hojreh
    Research Area: Radiation protection in Photon-Counting CT in peadiatrics; Childhood Interstitial Lung Diseases; Congenital Pulmonary Airway Malformation; Contrast Agent Safety; Hepatology and congenital biliary duct anomalies
    Members:

Research interests

  • Patient Safety (Radiation protection, MR-safety, contrast agents safety)
  • Paediatric Pulmonology incl. Cystic Fibrosis, ChILD and Congenital Pulmonary Airway Malformations
  • Pediatric Hepatology and Gastroenterology
  • Diseases of Kidneys and Urinary Tracts.

Techniques, methods & infrastructure

  • CT, MRI, ultrasound, digital diagnostic radiography, fluoroscopy
  • Multidisciplinary clinical and research collaborations
  • National and internation collaboration 

Selected publications

  1. Sidpra, J. et al. (2025) ‘International guidelines for the imaging investigation of suspected child physical abuse (IGISPA): a protocol for a modified Delphi consensus study’, BMJ Open, 15(9), p. e101693. Available at: https://doi.org/10.1136/bmjopen-2025-101693.
  2. Hojreh, A. et al. (2024) ‘Acute adverse reactions after multiple initially well-tolerated gadolinium-based contrast-enhanced abdomen MRIs in pediatric patients’, PLOS ONE. Edited by S. Ren, 19(12), p. e0313495. Available at: https://doi.org/10.1371/journal.pone.0313495.
  3. Hojreh, A. et al. (2023) ‘Reliability of signal intensity in the basal ganglia on non-contrast T1-weighted MR scans after repetitive application of a gadolinium-based contrast agent in pediatric neuro-oncology patients’, European Journal of Radiology, 169, p. 111179. Available at: https://doi.org/10.1016/j.ejrad.2023.111179.
  4. Hojreh, A. et al. (2023) ‘Relative Enhancement in Gadoxetate Disodium-Enhanced Liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic Fatty Liver Disease in Pediatric Obesity’, Nutrients, 15(3), p. 558. Available at: https://doi.org/10.3390/nu15030558.
  5. Hojreh, A. et al. (2022) ‘Influence of age on gadoxetic acid disodium-induced transient respiratory motion artifacts in pediatric liver MRI’, PLOS ONE. Edited by X. Chen, 17(3), p. e0264069. Available at: https://doi.org/10.1371/journal.pone.0264069.